(Q34585175)

3 August 2017

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis (English)

1 reference

3 August 2017

0 references

0 references

hepatocellular carcinoma

1 reference

Vanessa L Gates

10

0 references

Riad Salem

object named as

Riad Salem

13

0 references

Brian I. Carr

object named as

Brian I Carr

2

0 references

Reed A. Omary

12

object named as

Reed A Omary

1 reference

3 August 2017

Laura M Kulik

1

1 reference

3 August 2017

Mary F Mulcahy

3

1 reference

3 August 2017

Robert J Lewandowski

4

1 reference

3 August 2017

Bassel Atassi

5

1 reference

3 August 2017

Robert K Ryu

6

1 reference

3 August 2017

Kent T Sato

7

1 reference

3 August 2017

Al Benson

8

1 reference

3 August 2017

Albert A Nemcek

9

1 reference

3 August 2017

Michael Abecassis

11

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

3 August 2017

1 reference

3 August 2017

47

1 reference

3 August 2017

1

1 reference

3 August 2017

71-81

1 reference

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.

3 August 2017

1 reference

Chemoembolization of hepatic neoplasms: safety, complications, and when to worry

21 January 2018

1 reference

Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients

21 January 2018

1 reference

7 January 2021

Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation

1 reference

7 January 2021

Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement

1 reference

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

7 January 2021

Hepatic chemoembolization: safety with portal vein thrombosis

1 reference

7 January 2021

Chemoembolization of hepatocellular carcinoma

1 reference

7 January 2021

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

1 reference

7 January 2021

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

7 January 2021

Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.

1 reference

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

7 January 2021

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

7 January 2021

Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver Cancer

1 reference

7 January 2021

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

1 reference

7 January 2021

Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors

1 reference

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

7 January 2021

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases

1 reference

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

7 January 2021

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

1 reference

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

7 January 2021

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

7 January 2021

Management of hepatocellular carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21980

1 reference

3 August 2017

1 reference